Psychiatric issues often manageable during Parkinson’s infusion therapy

A real-world study found that psychiatric issues, including hallucinations and delusions, developed in some people with advanced Parkinson’s disease after they started Vyalev (foscarbidopa and foslevodopa), but most were manageable with infusion-rate adjustments or low-dose antipsychotic medications

Source: Parkinson's News Today.

Read the original report from Parkinson's News Today

Browse Parkinson's news and research